Earnings History Data for Verona Pharma plc (VRNA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Verona Pharma plc
Verona Pharma plc is a clinical-stage biopharmaceutical company. It researches, discovers and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. Verona Pharma plc is based in London, the United Kingdom.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 04-11-2024 | PM | VRNA | Verona Pharma plc | 2,760 | -0.56 | -0.44 | -0.18 | Verona Pharma reports Q3 results [11/4/2024 2:06 AM] |
37.95 | 2.97 (8.49%) |
33.01 | -1.97 (-5.63%) |
11.39 - 39.38 | 3,041,878 | 840,000 | 39,300 | ||
| 08-08-2024 | PM | VRNA | Verona Pharma plc | 1,700 | -0.88 | -0.35 | -0.11 | Verona Pharma GAAP EPS of -$0.11 beats by $0.10 [8/8/2024 2:34 AM] |
21.45 | 1.92 (9.83%) |
19.85 | 0.32 (1.64%) |
11.39 - 23.72 | 1,030,568 | 840,000 | 3,357 | ||
| 09-05-2024 | PM | VRNA | Verona Pharma plc | 1,200 | -0.32 | -0.24 | -0.24 | Verona Pharma GAAP EPS of -$0.04 beats by $0.09 [5/9/2024 7:23 AM] |
14.79 | -0.09 (-0.60%) |
15.14 | 0.26 (1.75%) |
11.83 - 23.81 | 643,434 | 450,000 | 14,797 | ||
| 29-02-2024 | PM | VRNA | Verona Pharma plc | 1,410 | -0.16 | -0.23 | -0.16 | Verona Pharma Non-GAAP EPS of -$0.02 [2/29/2024 2:50 AM] |
17.23 | -0.03 (-0.17%) |
18.25 | 0.99 (5.74%) |
11.83 - 23.81 | 482,978 | 490,000 | 625 | ||
| 02-11-2023 | PM | VRNA | Verona Pharma plc | 1,110 | -0.18 | -0.27 | -0.24 | Verona Pharma GAAP EPS of -$0.02 beats by $0.14 [11/2/2023 3:22 AM] |
14.94 | 0.66 (4.62%) |
14.94 | 0.0 (0.00%) |
11.56 - 26.44 | 340,936 | 560,000 | 4,559 | ||
| 03-08-2023 | PM | VRNA | Verona Pharma plc | 1,700 | -0.11 | -0.27 | -0.32 | Verona Pharma GAAP EPS of -$0.01 beats by $0.20 [8/3/2023 2:02 AM] |
20.04 | -0.60 (-2.88%) |
20.04 | 0.0 (0.00%) |
5.70 - 26.44 | 376,851 | 270,000 | 5,313 | ||
| 09-05-2023 | PM | 2:00 AM ET (May 9) |
VRNA | Verona Pharma plc | 1,710 | -0.24 | -0.22 | -0.40 | Verona Pharma GAAP EPS of -$0.03 beats by $0.08 [5/9/2023 2:12 AM] |
22.46 | 0.59 (2.70%) |
0.0 | 0.0 (0.00%) |
3.41 - 26.44 | 193,330 | 400,000 | 0 | |
| 07-03-2023 | PM | 2:00 AM ET (Mar 7) |
VRNA | Verona Pharma plc | 1,610 | -0.16 | -0.22 | -0.40 | Verona Pharma GAAP EPS of -$0.02 beats by $0.03 [3/7/2023 6:14 AM] |
20.14 | -2.31 (-10.29%) |
0.0 | 0.0 (0.00%) |
3.41 - 26.44 | 1,287,351 | 420,000 | 0 | |
| 09-11-2022 | PM | 3:00 AM ET (Nov 9) |
VRNA | Verona Pharma plc | 769.24 | -0.24 | -0.30 | 0.17 | Verona Pharma GAAP EPS of -$0.03 beats by $0.10 [11/9/2022 2:33 AM] |
12.36 | -0.57 (-4.41%) |
13.00 | 0.07 (0.54%) |
3.41 - 14.69 | 244,809 | 260,000 | 217 | |
| 09-08-2022 | PM | 2:00 AM ET (Aug 15) |
VRNA | Verona Pharma | 404.00 | -0.32 | -0.35 | 0.00 | Verona Pharma GAAP EPS of -$0.04 beats by $0.23 [8/9/2022 3:58 AM] |
10.07 | 3.12 (44.89%) |
14.10 | 7.15 (102.87%) |
3.41 - 14.69 | 23,665,579 | 110,000 | 12,914,902 | |
| 03-05-2022 | PM | 2:00 AM ET (May 3) |
VRNA | Verona Pharma | 251.00 | -0.40 | -0.47 | 0.00 | Verona Pharma GAAP EPS of -$0.05 beats by $0.24 [5/3/2022 2:08 AM] |
4.07 | 0.17 (4.36%) |
0.0 | 0.0 (0.00%) |
3.66 - 7.87 | 201,565 | 140,000 | 0 | |
| 03-03-2022 | PM | 2:00 AM ET (Mar 3) |
VRNA | Verona Pharma plc | 337.26 | -0.40 | -0.50 | -0.53 | Verona Pharma GAAP EPS of -$0.05 beats by $0.30 [3/3/2022 2:52 AM] |
5.44 | -0.07 (-1.27%) |
0.0 | 0.0 (0.00%) |
3.66 - 9.27 | 1,918 | 80,000 | 0 | |
| 09-11-2021 | PM | 2:00 AM ET (Nov 9) |
VRNA | Verona Pharma plc | 300.78 | 0.17 | -0.19 | -0.46 | Verona Pharma EPS beats by $0.27 [11/9/2021 2:07 AM] |
5.21 | 0.04 (0.77%) |
5.29 | 0.12 (2.32%) |
4.45 - 9.72 | 91,041 | 30,000 | 3,370 | |
| 05-08-2021 | PM | 2:00 AM ET (Aug 5) |
VRNA | Verona Pharma plc | 364.04 | -0.56 | -0.39 | -0.68 | Verona Pharma EPS beats by $0.42 [8/5/2021 2:09 AM] |
6.25 | 0.28 (4.69%) |
5.97 | 0.0 (0.00%) |
5.31 - 9.72 | 45,614 | 30,000 | 190 | |
| 29-04-2021 | PM | 2:00 AM ET (Apr 29) |
VRNA | Verona Pharma plc | 445.93 | -0.55 | -0.45 | -0.94 | Verona Pharma EPS beats by $0.43 [4/29/2021 2:23 AM] |
6.80 | -0.40 (-5.56%) |
0.0 | 0.0 (0.00%) |
3.70 - 15.71 | 126,702 | 40,000 | 0 | |
| 25-02-2021 | PM | 0:00 AM ET (Feb 25) |
VRNA | Verona Pharma plc | 482.95 | -0.53 | -0.34 | -0.72 | Verona Pharma EPS beats by $0.30 [2/25/2021 2:26 AM] |
9.26 | 0.12 (1.31%) |
9.88 | 0.74 (8.10%) |
2.01 - 15.71 | 156,593 | 115,497 | 112 | |
| 29-10-2020 | PM | VRNA | Verona Pharma Plc American Depositary Share | 79.00 | -0.46 | -0.21 | 0.00 | Verona Pharma EPS beats by $0.15 [10/29/2020 3:08 AM] |
5.77 | -0.04 (-0.69%) |
0.0 | 0.0 (0.00%) |
2.01 - 15.71 | 61,081 | 69,273 | 0 | ||
|
|
||||||||||||||||||